329 related articles for article (PubMed ID: 28070247)
1. Effectiveness of cognitive behavioral therapy and fluoxetine on sexual function of women with obsessive compulsive disorder: A double-blind randomized controlled trial.
Sabetnejad Z; Assarian F; Omidi A; Najarzadegan MR
Electron Physician; 2016 Nov; 8(11):3156-3163. PubMed ID: 28070247
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of transcranial direct current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder: a randomized, double-blind, sham-controlled, clinical trial.
Yoosefee S; Amanat M; Salehi M; Mousavi SV; Behzadmanesh J; Safary V; Yoonesi A; Salehi B
BMC Psychiatry; 2020 Nov; 20(1):570. PubMed ID: 33256659
[TBL] [Abstract][Full Text] [Related]
3. Therapist-Assisted Internet-Based Cognitive Behavioral Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized Controlled Trial.
Kyrios M; Ahern C; Fassnacht DB; Nedeljkovic M; Moulding R; Meyer D
J Med Internet Res; 2018 Aug; 20(8):e242. PubMed ID: 30089607
[TBL] [Abstract][Full Text] [Related]
4. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.
Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M
BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014
[TBL] [Abstract][Full Text] [Related]
5. Reboxetine Combination Therapy With Fluoxetine in Moderate to Severe Obsessive-Compulsive Disorder: A Placebo-Controlled, Double-Blind, Randomized Trial.
Tilaki EH; Hasanzadeh A; Shalbafan M; Moghaddam HS; Shamabadi A; Boroon M; Akhondzadeh S
Clin Neuropharmacol; 2023 Sep-Oct 01; 46(5):175-180. PubMed ID: 37747999
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
[TBL] [Abstract][Full Text] [Related]
7. Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: a randomized clinical controlled trial.
Javaherirenani R; Mortazavi SS; Shalbafan M; Ashouri A; Farani AR
BMC Psychiatry; 2022 Nov; 22(1):740. PubMed ID: 36443695
[TBL] [Abstract][Full Text] [Related]
8. Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial.
Shokrani M; Askari S; Eissazade N; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M
BMC Psychiatry; 2023 Sep; 23(1):686. PubMed ID: 37735631
[TBL] [Abstract][Full Text] [Related]
9. Telephone cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a randomized controlled non-inferiority trial.
Turner CM; Mataix-Cols D; Lovell K; Krebs G; Lang K; Byford S; Heyman I
J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1298-1307.e2. PubMed ID: 25457928
[TBL] [Abstract][Full Text] [Related]
10. Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial.
Ma JD; Wang CH; Li HF; Zhang XL; Zhang YL; Hou YH; Liu XH; Hu XZ
J Psychiatr Res; 2013 Nov; 47(11):1785-90. PubMed ID: 23988179
[TBL] [Abstract][Full Text] [Related]
11. Feasibility, Acceptability, and Effectiveness of Enhanced Cognitive Behavioral Therapy (eCBT) for Children and Adolescents With Obsessive-Compulsive Disorder: Protocol for an Open Trial and Therapeutic Intervention.
Wolters LH; Weidle B; Babiano-Espinosa L; Skokauskas N
JMIR Res Protoc; 2020 Dec; 9(12):e24057. PubMed ID: 33203621
[TBL] [Abstract][Full Text] [Related]
12. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder.
Hoexter MQ; Dougherty DD; Shavitt RG; D'Alcante CC; Duran FL; Lopes AC; Diniz JB; Batistuzzo MC; Evans KC; Bressan RA; Busatto GF; Miguel EC
Eur Neuropsychopharmacol; 2013 Jul; 23(7):569-80. PubMed ID: 22841131
[TBL] [Abstract][Full Text] [Related]
13. Comparing the effects of treatment with sildenafil and cognitive-behavioral therapy on treatment of sexual dysfunction in women: a randomized controlled clinical trial.
Omidi A; Ahmadvand A; Najarzadegan MR; Mehrzad F
Electron Physician; 2016 May; 8(5):2315-24. PubMed ID: 27382439
[TBL] [Abstract][Full Text] [Related]
14. A study of cognitive function in treatment-refractory obsessive-compulsive disorder treated with capsulotomy.
Gong F; Li P; Li B; Zhang S; Zhang X; Yang S; Liu H; Wang W
J Neurosurg; 2018 Feb; 128(2):583-595. PubMed ID: 28338440
[TBL] [Abstract][Full Text] [Related]
15. [Can the efficacy of behavioral and cognitive therapy for obsessive compulsive disorder be augmented by innovative computerized adjuvant?].
Morgiève M; N'Diaye K; Clair AH; Pelissolo A; Mallet L
Encephale; 2016 Oct; 42(5):402-409. PubMed ID: 27109326
[TBL] [Abstract][Full Text] [Related]
16. Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial.
Lenhard F; Andersson E; Mataix-Cols D; Rück C; Vigerland S; Högström J; Hillborg M; Brander G; Ljungström M; Ljótsson B; Serlachius E
J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):10-19.e2. PubMed ID: 27993223
[TBL] [Abstract][Full Text] [Related]
17. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
[TBL] [Abstract][Full Text] [Related]
18. Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive-compulsive disorder: A double blind randomized clinical trial.
Kazemi F; Vosough I; Sepahi S; Mohajeri SA
Hum Psychopharmacol; 2021 Jul; 36(4):e2780. PubMed ID: 33599345
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness of Group Cognitive Behavioral Therapy in Treating Obsessive-Compulsive Disorder in Women with Multiple Sclerosis (MS): A randomized double-blind controlled trial.
Sayyah M; Bagheri P; Karimi N; Ghasemzadeh A
Electron Physician; 2016 Apr; 8(4):2243-8. PubMed ID: 27279999
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of unguided self-help psychological interventions for obsessive-compulsive disorder: A meta-analysis of randomized controlled trials.
Wang Y; Amarnath A; Miguel C; Ciharova M; Lin J; Zhao R; Struijs SY; de Wit LM; Toffolo MBJ; Cuijpers P
Compr Psychiatry; 2024 Apr; 130():152453. PubMed ID: 38290294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
